secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0000950170-25-051218
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health closes $3.45M convertible note private placement with warrants
----------------------------------------------------------------------------

- Issued $3.448M aggregate principal of convertible notes; 6% interest, 3-month maturity, immediately convertible.
- Warrants to purchase up to 622,584 shares of common stock; 5-year term, exercisable immediately.
- Participants include CEO Lisa Conte, board members, and senior executives alongside institutional investors.
- H.C. Wainwright acted as exclusive placement agent; net proceeds for working capital and general corporate purposes.
- Company agreed to file a resale registration statement covering shares underlying the notes and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025051218/0000950170-25-051218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000095017025051218/jagx-20250331.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-051218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer